Long-term efficacy and safety of pegvisomant therapy in acromegaly

Endocr Pract. 2015 Mar;21(3):296-8. doi: 10.4158/EP14566.CO.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acromegaly / drug therapy*
  • Female
  • Human Growth Hormone / analogs & derivatives*
  • Humans
  • Male
  • Receptors, Somatotropin / antagonists & inhibitors*

Substances

  • Receptors, Somatotropin
  • Human Growth Hormone